DoD Prostate Cancer Dr. Barbara Terry-Koroma Health Disparity Research Award

The summary for the DoD Prostate Cancer Dr. Barbara Terry-Koroma Health Disparity Research Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Prostate Cancer Dr. Barbara Terry-Koroma Health Disparity Research Award: The PCRP Health Disparity Research Award mechanism was first offered in FY01. Since then, 321 Health Disparity Research Award applications have been received, and 69 have been recommended for funding. The Health Disparity Research Award supports new ideas based on innovative concepts or methodologies for health disparity research with the potential to make an important contribution toward eliminating death from prostate cancer and enhancing the well-being of men impacted by the disease. Studies proposed for this award mechanism are expected to improve the understanding of, and ultimately contribute to eliminating, disparities in prostate cancer incidence, morbidity, mortality, and survivorship. Applicants for this award must explicitly state how the proposed research is related to an area of prostate cancer health disparity. Appropriate health disparity areas include, but are not limited to, race and ethnicity, socioeconomic status, access to or differing standards of health care, insurance status, age, geography, sexual orientation, gender identity, and cultural beliefs. The PCRP seeks applications from investigators from a wide spectrum of disciplines including, but not limited to, basic science, engineering, bioinformatics, population science, translational research, and clinical research, provided they are appropriately focused on an issue of prostate cancer health disparity. In addition, all applications are expected to be relevant to one or more of the PCRP focus areas and are encouraged to be responsive to one of the PCRP overarching challenges. If the proposed project does not address one of the overarching challenges, the application must provide a description to justify how the project will nevertheless address a critical disparity-related need in the field of prostate cancer research and/or patient care. Research involving human subject use is permitted under this funding opportunity, but is restricted to studies without clinical trials; however, correlative studies, including studies with populations from existing clinical trials, are allowed. For definitions and other information on clinical trials and clinical research overall, a Human Subject Resource Document is provided on the eBRAP System at https://ebrap.org/eBRAP/public/Program.htm. New Investigators: This award encourages applications from investigators in the early stages of their careers. The New Investigator category is designed to allow PIs, early in their faculty appointments or in the process of developing independent research careers, to compete for funding separately from established investigators. Applications from New Investigators and Established Investigators will be peer and programmatically reviewed separately. PIs using the New Investigator category are strongly encouraged to strengthen their applications by including investigators experienced in prostate cancer research and/or possessing other relevant expertise as demonstrated by a record of funding and publications. It is the responsibility of the PI to describe how additional investigators will augment his/her expertise and better address the research question. PIs may choose to employ both the New Investigator category and the Qualified Collaborator Option (described below) in a single application. All applicants for the New Investigator category must meet specific eligibility criteria, as described in Section I.C., Eligibility Information. The Health Disparity Research Award offers two additional options for consideration: 1. Qualified Collaborator Option: The Health Disparity Research Award strongly supports collaborative research involving basic, population science, and clinical researchers, researchers with prostate cancer expertise and those with health disparity expertise, and/or researchers and community organizations that may be critical to the study of populations disproportionately affected by prostate cancer. Although these and other types of collaborations are, in general, strongly encouraged, collaborations that meet specific criteria will qualify for a higher level of funding, as described in Section I.D., Funding. For the application to qualify for a higher level of funding, the PI must submit a Qualified Collaboration Statement that clearly describes the proposed collaborator and collaboration and addresses how each of the criteria below are met. In addition, the collaborator must provide a letter of collaboration describing his/her involvement in the proposed work. It should be clear from both documents that the successful completion of the project depends on the unique skills and contributions of both the PI and the qualified collaborator. The following criteria must be met to use the Qualified Collaborator Option: • The collaborator must significantly contribute to the project such that the proposed work could not be accomplished without his/her involvement. This is expected to include both intellectual input and research resources (e.g., supplies, reagents, equipment, personnel, services, tissue samples, or access to patients or populations). • The collaborator must contribute at least a 10% level of effort to the project. Contribution of the collaborator should be reflected in the application budget. • If the PI does not have experience in prostate cancer research and/or working with disproportionately affected populations, the collaborator must possess such experience. 2. Nested Health Disparity Traineeship Option: This award also offers opportunities for training highly motivated graduate students and postdoctoral fellows interested in pursuing a career in resolving disparities in prostate cancer incidence, morbidity, mortality, and survivorship. The trainee is not required to have previous health disparity or prostate cancer research experience. This option primarily provides salary support for the trainee. An individualized training program in prostate cancer disparities must be described, and may include coursework, laboratory techniques, conferences, seminars, journal clubs, teaching responsibilities, clinical responsibilities, grant writing and/or other activities that will provide the trainee with experience in key areas relevant to the proposed work and foster the trainee’s development as a prostate cancer health disparity researcher. An environment appropriate to the proposed training must be clearly described. Only one traineeship (predoctoral or postdoctoral) may be requested per application. Plans for training and mentorship must be well developed and clearly described by the PI in the application.
Federal Grant Title: DoD Prostate Cancer Dr. Barbara Terry-Koroma Health Disparity Research Award
Federal Agency Name: Dept of the Army USAMRAA
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: W81XWH-14-PCRP-HDRA
Type of Funding: Cooperative Agreement, Grant
CFDA Numbers: 12.420
CFDA Descriptions: Military Medical Research and Development
Current Application Deadline: Sep 24, 2014
Original Application Deadline: Sep 24, 2014
Posted Date: May 30, 2014
Creation Date: May 30, 2014
Archive Date: Oct 24, 2014
Total Program Funding: $5,800,000
Maximum Federal Grant Award: $0
Minimum Federal Grant Award: $0
Expected Number of Awards: 6
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
CDMRP Help Desk 301-682-5507
CDMRP Help Desk

Dept. of the Army -- USAMRAA 301-619-7144
Similar Government Grants
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research a...
DoD Kidney Cancer, Clinical Consortium Award
DOD Toxic Exposures, Translational Research Award
DOD Toxic Exposures, Investigator-Initiated Research Award
DOD Toxic Exposures, Clinical Trial Award
FY2006 Deployed War Fighter Protection Research Program
Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
More Grants from the Dept of the Army USAMRAA
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research a...
DoD Kidney Cancer, Clinical Consortium Award
DOD Toxic Exposures, Translational Research Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com